Schedule 13D ownership disclosure
ADIAL PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00688A106
Event date: 2022-02-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-008326
- Form type
- SC 13D
- Filer
- ADIAL PHARMACEUTICALS, INC.
- CIK
- CIK 1513525
- Filed
- Feb 18, 2022
- Reporting period
- Feb 15, 2022
- Description
- Schedule 13D beneficial ownership